Industry Newsroom

Hillhouse Capital to Invest USD310m in Chinese Drug Maker Joincare via Private Placement

Hillhouse Capital has agreed to invest USD310m in Shanghai-listed drug maker Joincare Pharmaceutical Group Industry through a private placement for an 8% stake. Read more